Zofia Monika Rupniewska
Zofia Monika Rupniewska publishes mostly in Genetics, Plant Science and Hematology, on topics such as Chronic Lymphocytic Leukemia Research, Agriculture, Plant Science, Crop Management and Glycosylation and Glycoproteins Research.
- World rank
- #7,085,990 of 7,710,434 ranked researchers
- Rank in Poland
- #82,998 of 100,960
- Works
- 27
- Citations
- 28
- Citations per work
- 1.0
What does Zofia Monika Rupniewska research?
Zofia Monika Rupniewska's work is mostly in Medicine (34%), Agricultural and Biological Sciences (10%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1142.1%
- Health Sciences934.2%
- Medicine934.2%
- Life Sciences623.7%
- 1Genetics18% of their works
- 2Plant Science10% of their works
- 3Hematology10% of their works
- 4Immunology8% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Molecular Biology5% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Agriculture, Plant Science, Crop Management
- Glycosylation and Glycoproteins Research
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Zofia Monika Rupniewska's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Glycosylation, Nutrient Sources, Organic Fertilizers and Acute Lymphoblastic Leukemia.
- Lymphoma
- Glycans
- Classification
- Cancer
- Acute Myeloid Leukemia
- AML
- Nutrient Sources
- Genomic Aberrations
- Rituximab
- Prognostic Factors
- Chronic Lymphocytic Leukemia
- Glycosylation
- Organic Fertilizers
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Childhood Cancer
- Fc Receptors
- Imatinib
- Therapeutic Antibodies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors113 topics
- Rituximab92 topics
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- Glycosylation42 topics
- Nutrient Sources31 topic
- Organic Fertilizers31 topic
- AML21 topic
- Acute Lymphoblastic Leukemia21 topic
- Acute Myeloid Leukemia21 topic
- BCR-ABL21 topic
- Cancer21 topic
- Childhood Cancer21 topic
- Classification21 topic
- Fc Receptors21 topic
- Glycans21 topic
- Imatinib21 topic
- Lymphoma21 topic
- Therapeutic Antibodies21 topic
Where does Zofia Monika Rupniewska work?
Zofia Monika Rupniewska's main affiliation in the publication record is University of Economics and Innovation, Poland.
How many publications and citations does Zofia Monika Rupniewska have?
OpenAlex counts 27 works and 28 citations for Zofia Monika Rupniewska, an h-index of 2, ranking #7,085,990 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Zofia Monika Rupniewska. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.